阿斯利康宣布追加投资约1.36亿美元 扩大青岛生产供应基地产能

Core Viewpoint - AstraZeneca has signed a strategic cooperation agreement with the Qingdao High-tech Industrial Development Zone Management Committee to invest approximately $136 million to expand production capacity in Qingdao [1] Group 1: Investment Details - The investment aims to enhance the production capacity of AstraZeneca's inhalation aerosol products [1] - The expansion is intended to better meet the treatment needs of patients with respiratory diseases such as asthma and COPD [1]